ABOUT PINPOINT


Our Portfolio
PCD – Non-Invasive Prostate Cancer Screening
PCD is a breakthrough diagnostic platform for early-stage prostate cancer detection—offering rapid, non-invasive, point-of-care testing with results in under 30 minutes and a current accuracy rate of 75%. Designed to improve patient comfort, accessibility, and early intervention, PCD is set to redefine the landscape of preventative oncology. Its underlying biosensing technology also holds future potential for liver and bowel cancer diagnostics.
Plasmonic Assay – Advanced Biosensors
Our Disposable Plasmonic Assay (DPA) biosensors are engineered for high-precision, real-time pathogen detection. Capable of identifying multiple infectious agents from a single sample, these cost-effective, rapid diagnostics are ideal for high-throughput use in hospitals, schools, transport hubs, and other high-risk environments. With scalable deployment and fast results, DPA biosensors support smarter, faster responses to infectious threats.
Pinpoint iAQ – Intelligent Air Quality System
The Pinpoint iAQ System is a next-generation, modular air purification and monitoring solution. Combining nano-structured filtration, UV-A and UV-C sterilisation, and real-time biosensing, it delivers continuous environmental monitoring for healthcare, laboratories, and enclosed public spaces. iAQ ensures air quality is actively managed—reducing airborne transmission risks and improving safety in critical environments.